U.S. equities rose at midday ahead of the latest announcement from the Federal Reserve, as President Donald Trump again ...

Ticks are spreading globally and bringing familiar conditions such as Lyme disease with them, as well as totally new ones.

Shares of a little-known Chinese herbal medicine company have surged this year, with a fresh rally seeing the price quadruple ...

GSK GSK stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, ...

If you want a vehicle to compound your investments for the coming decades or you just want a passive income source, ...

A few of the new members Health Secretary Robert F. Kennedy Jr. appointed to the federal vaccine panel have promoted ...

BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump ...

Shares in Hong Kong-based Regencell Bioscience Holdings nearly quadrupled in value amid a 38-to-1 stock split despite the ...

Novavax, Inc. faces profitability challenges despite a promising tech platform, with uncertain revenue streams. Click for my ...

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it ...